• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast: another causality dilemma?

作者信息

Van Bockstal M, Libbrecht L, Floris G, Lambein K, Pinder S

机构信息

Department of Pathology, Ghent University Hospital, Ghent.

Department of Medical and Forensic Pathology & Cancer Research Institute Ghent (CRIG), Ghent University, Ghent.

出版信息

Ann Oncol. 2017 Sep 1;28(9):2317. doi: 10.1093/annonc/mdx253.

DOI:10.1093/annonc/mdx253
PMID:28911076
Abstract
摘要

相似文献

1
Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast: another causality dilemma?乳腺导管原位癌中的间质炎症、坏死及HER2过表达：另一个因果关系困境？
Ann Oncol. 2017 Sep 1;28(9):2317. doi: 10.1093/annonc/mdx253.
2
HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.通过荧光原位杂交和免疫组织化学检测纯导管原位癌以及浸润性导管癌的导管内和浸润成分中的HER2状态。
Histopathology. 2006 May;48(6):702-7. doi: 10.1111/j.1365-2559.2006.02403.x.
3
Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.HER2/Neu在乳腺导管原位癌及非典型导管增生性病变中的可能预后作用
Asian Pac J Cancer Prev. 2016;17(8):3733-6.
4
The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.HER2/neu过表达/扩增在乳腺导管原位癌进展为浸润性癌过程中的作用。
Mod Pathol. 2002 Dec;15(12):1318-25. doi: 10.1097/01.MP.0000038462.62634.B1.
5
HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?非扩增性导管原位癌中HER2蛋白过表达：质量问题还是转录机制出错？
Histopathology. 2019 Mar;74(4):666-668. doi: 10.1111/his.13799. Epub 2019 Jan 15.
6
In reply to Lambein et al.: 'HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?'.回复兰贝因等人：“非扩增性导管原位癌中HER2蛋白过表达：质量问题还是转录机制出错？”
Histopathology. 2019 Mar;74(4):666. doi: 10.1111/his.13792. Epub 2019 Jan 15.
7
Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.原发性导管原位癌（DCIS）与相应局部病变之间乳腺癌受体的克隆性改变。
Eur J Cancer. 2014 Feb;50(3):517-24. doi: 10.1016/j.ejca.2013.10.020. Epub 2013 Nov 22.
8
Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes.乳腺钼靶筛查发现的导管原位癌：基于乳腺癌亚型的钼靶特征
Clin Imaging. 2015 Nov-Dec;39(6):983-6. doi: 10.1016/j.clinimag.2015.06.006. Epub 2015 Jul 16.
9
Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.乳腺癌亚组间HER2扩增状态的比较为乳腺癌进展途径提供了新见解。
Virchows Arch. 2017 Nov;471(5):575-587. doi: 10.1007/s00428-017-2161-8. Epub 2017 May 31.
10
Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.三阴性乳腺癌中的大汗腺癌：大汗腺型浸润性导管癌为雌激素/孕激素受体阴性、雄激素受体阳性的新型定义。
Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26.

引用本文的文献

1
Quantitative assessment of HER2 expression in invasive ductal carcinoma and co-existing DCIS.浸润性导管癌及并存的导管原位癌中HER2表达的定量评估。
Breast Cancer Res Treat. 2025 Jul 18. doi: 10.1007/s10549-025-07781-9.
2
DCIS Progression and the Tumor Microenvironment: Molecular Insights and Prognostic Challenges.导管原位癌进展与肿瘤微环境：分子见解与预后挑战
Cancers (Basel). 2025 Jun 10;17(12):1925. doi: 10.3390/cancers17121925.
3
Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance.
系统评估乳腺导管原位癌的 HER2 状态：潜在临床相关性的视角。
Breast Cancer Res. 2024 Aug 27;26(1):125. doi: 10.1186/s13058-024-01875-w.